PACMEL: A phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxel

Trametinib can safely be given with weekly paclitaxel at the full monotherapy dose. In this small group promising progression free and overall survival were observed in patients with melanoma lacking a V600 BRAF mutation.